PL2331687T3 - Środki przeciwdrobnoustrojowe - Google Patents
Środki przeciwdrobnoustrojoweInfo
- Publication number
- PL2331687T3 PL2331687T3 PL09782176T PL09782176T PL2331687T3 PL 2331687 T3 PL2331687 T3 PL 2331687T3 PL 09782176 T PL09782176 T PL 09782176T PL 09782176 T PL09782176 T PL 09782176T PL 2331687 T3 PL2331687 T3 PL 2331687T3
- Authority
- PL
- Poland
- Prior art keywords
- antimicrobials
- Prior art date
Links
- 239000004599 antimicrobial Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2462—Lysozyme (3.2.1.17)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0815484.1A GB0815484D0 (en) | 2008-08-26 | 2008-08-26 | Antibacterial agents |
| PCT/EP2009/060947 WO2010023207A2 (en) | 2008-08-26 | 2009-08-25 | Antimicrobial agents |
| EP09782176A EP2331687B1 (en) | 2008-08-26 | 2009-08-25 | Antimicrobial agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2331687T3 true PL2331687T3 (pl) | 2013-02-28 |
Family
ID=39846783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09782176T PL2331687T3 (pl) | 2008-08-26 | 2009-08-25 | Środki przeciwdrobnoustrojowe |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9809808B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2331687B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP5153943B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101473271B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN102197132B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2009286760B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0917508A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2735077C (cg-RX-API-DMAC7.html) |
| DK (1) | DK2331687T3 (cg-RX-API-DMAC7.html) |
| EA (1) | EA024794B1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2395357T3 (cg-RX-API-DMAC7.html) |
| GB (1) | GB0815484D0 (cg-RX-API-DMAC7.html) |
| IL (1) | IL211441A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2011001957A (cg-RX-API-DMAC7.html) |
| PL (1) | PL2331687T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010023207A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0815484D0 (en) | 2008-08-26 | 2008-10-01 | Univ Leuven Kath | Antibacterial agents |
| EP3714895A3 (en) | 2009-06-26 | 2020-11-25 | Lysando AG | Antimicrobial agents |
| WO2010149795A1 (en) * | 2009-06-26 | 2010-12-29 | Lysando Holding Establishment | Antimicrobial agents |
| EA024253B1 (ru) * | 2009-08-24 | 2016-08-31 | Катхолике Университейт Лёвен, К.У. Лёвен Р Энд Д | Литический полипептид с пептидогликангидролазной активностью и его применение против инфекций, вызванных грамотрицательными бактериями |
| DK2563916T3 (en) * | 2010-04-27 | 2015-10-05 | Lysando Ag | METHOD FOR REDUCING biofilms |
| PT3443970T (pt) * | 2010-09-17 | 2020-10-09 | Technophage Investig E Desenvolvimento Em Biotecnologia Sa | Fagos antibacterianos, péptidos fágicos e métodos de utilização dos mesmos |
| GB201018518D0 (en) | 2010-11-03 | 2010-12-15 | Univ Leuven Kath | Novel endolysin |
| EP2468856A1 (en) * | 2010-12-23 | 2012-06-27 | Lysando Aktiengesellschaft | Antimicrobial Agents |
| CN108578685A (zh) * | 2011-04-21 | 2018-09-28 | 洛克菲勒大学 | 用于革兰氏阳性菌检测和治疗的链球菌属细菌噬菌体溶素 |
| WO2012146738A1 (en) * | 2011-04-27 | 2012-11-01 | Lysando Holding Ag | New antimicrobial agents |
| US9068204B2 (en) | 2013-03-15 | 2015-06-30 | The United States Of America, As Represented By The Secretary Of Agriculture | Peptidoglycan hydrolase antimicrobials for eradicating lactobacilli that contaminate and reduce ethanol yields in biofuel fermentation |
| WO2015070912A1 (en) | 2013-11-14 | 2015-05-21 | Lysando Ag | Modified el188 endolysin sequence |
| WO2015070911A1 (en) * | 2013-11-14 | 2015-05-21 | Lysando Ag | Modified kz144 endolysin sequence |
| EP3105322B1 (en) | 2014-02-14 | 2018-12-12 | Lysando AG | Antimicrobial agents |
| AU2015243359B2 (en) * | 2014-04-08 | 2020-03-12 | Lysando Ag | Pharmaceutical composition against chronic bacterial infections |
| GB2543453A (en) | 2014-06-26 | 2017-04-19 | Univ Rockefeller | Acinetobacter lysins |
| CN104762285B (zh) * | 2015-04-23 | 2017-10-27 | 武汉菲吉乐科生物科技有限公司 | 一种自内裂解大肠杆菌的裂解酶及其应用 |
| JP7033596B2 (ja) * | 2016-12-16 | 2022-03-10 | ウニベルシダージ ド ミーニョ | 新規エンドリシン |
| US11208643B2 (en) * | 2017-04-03 | 2021-12-28 | Sasinapas Co., Ltd. | Engineered gram-negative endolysins |
| BR112020011433A2 (pt) * | 2017-12-12 | 2020-12-01 | Contrafect Corporation | identificação de lisinas e seus derivados com atividade bacteriana contra pseudomonas aeruginosa |
| JP7515409B2 (ja) | 2018-05-30 | 2024-07-12 | ライサンド アーゲー | 新規抗微生物融合タンパク質 |
| AU2019276253A1 (en) | 2018-05-30 | 2020-11-26 | Lysando Ag | Novel antimicrobial proteins |
| AU2020268752B2 (en) * | 2019-05-08 | 2025-12-18 | BioNTech SE | Novel gardnerella endolysins and uses thereof |
| WO2023225518A2 (en) * | 2022-05-16 | 2023-11-23 | The Broad Institute, Inc. | Engineered pnma proteins and delivery systems thereof |
| CN117737001B (zh) * | 2022-12-27 | 2024-08-09 | 菲吉乐科(南京)生物科技有限公司 | 一种防治犬细菌性腹泻的大肠杆菌噬菌体及其应用 |
| CN118620800B (zh) * | 2024-08-08 | 2024-11-12 | 中国兽医药品监察所 | 一株鼻疽伯克霍尔德氏菌及其应用 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3854476T2 (de) | 1987-07-06 | 1996-04-04 | Univ Louisiana State | Inhibierung von eukaryotischen pathogenen und neoplasmen mit lytischen peptiden. |
| GB2255561B (en) * | 1991-04-20 | 1995-06-21 | Agricultural & Food Res | Lysins from bacteriophages |
| EP0656952B1 (en) * | 1992-08-21 | 2003-03-05 | The University Of British Columbia | Cationic peptides and method for production |
| PT778733E (pt) | 1994-09-01 | 2001-06-29 | Novozymes As | Composicao proteica basica para matar ou inibir celulas microbianas |
| US6503881B2 (en) | 1996-08-21 | 2003-01-07 | Micrologix Biotech Inc. | Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| US6428784B1 (en) * | 1997-10-31 | 2002-08-06 | New Horizons Diagnostics Corp | Vaginal suppository for treating group B Streptococcus infection |
| US5997862A (en) * | 1997-10-31 | 1999-12-07 | New Horizons Diagnostics Corporation | Therapeutic treatment of group A streptococcal infections |
| US6288212B1 (en) | 1998-08-28 | 2001-09-11 | The University Of British Columbia | Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor |
| US5993809A (en) | 1998-11-18 | 1999-11-30 | Children's Hospital Medical Center | Lysozyme fusion proteins in infections |
| AU5553600A (en) | 1999-06-23 | 2001-01-31 | Ppl Therapeutics (Scotland) Ltd | Fusion proteins incorporating lysozyme |
| KR20050016362A (ko) | 2002-04-22 | 2005-02-21 | 다우 글로벌 테크놀로지스 인크. | 펩티드의 저비용 생산 |
| US7566447B2 (en) | 2003-05-15 | 2009-07-28 | Iogenetics, Llc | Biocides |
| CA2536782A1 (en) | 2003-09-11 | 2005-03-17 | Novozymes A/S | Recombinant production of antimicrobial agents |
| WO2005108563A2 (en) | 2004-04-19 | 2005-11-17 | University Of Chicago | Peptidoglycan-hydrolyzing protein encoded by bacteriophage n4 |
| US7572602B1 (en) | 2004-12-03 | 2009-08-11 | The United States Of America As Represented By The Secretary Of Agriculture | Nucleic acid encoding endolysin fusion protein |
| DE102005040347A1 (de) | 2005-08-25 | 2007-03-01 | Profos Ag | Verfahren und Mittel zur Anreicherung, Entfernung und zum Nachweis von Listerien |
| EP2004215B1 (en) | 2006-03-31 | 2010-06-09 | The University Court of the University of St. Andrews | Anti-microbial compositions comprising a cationic peptide and a glycylglycine endopeptidase |
| DE102006061002A1 (de) * | 2006-12-22 | 2008-06-26 | Profos Ag | Verfahren und Mittel zur Anreicherung, Entfernung und zum Nachweis von gram-positiven Bakterien |
| EP3327030B1 (en) | 2007-09-25 | 2021-07-21 | Pastoral Greenhouse Gas Research LTD | Vaccines and vaccine components for inhibition of microbial cells |
| US20100310522A1 (en) | 2007-11-26 | 2010-12-09 | Plant Bioscience Limited | Novel Polypeptides Having Endolysin Activity and Uses Thereof |
| EP2318531A4 (en) | 2008-07-24 | 2011-11-09 | Us Agriculture | TO RESISTANCE DEVELOPMENT REFRACTORY ANTIMICROBIAL ACTIVE SUBSTANCES |
| EP2157100A1 (en) | 2008-08-19 | 2010-02-24 | Profos AG | Artificial peptidoglycan lysing enzymes and peptidoglycan binding proteins |
| GB0815484D0 (en) | 2008-08-26 | 2008-10-01 | Univ Leuven Kath | Antibacterial agents |
| WO2010091294A2 (en) | 2009-02-05 | 2010-08-12 | The Regents Of The University Of California | New targeted antimicrobial moieties |
| EP3714895A3 (en) | 2009-06-26 | 2020-11-25 | Lysando AG | Antimicrobial agents |
| EA024253B1 (ru) | 2009-08-24 | 2016-08-31 | Катхолике Университейт Лёвен, К.У. Лёвен Р Энд Д | Литический полипептид с пептидогликангидролазной активностью и его применение против инфекций, вызванных грамотрицательными бактериями |
| DK2563916T3 (en) | 2010-04-27 | 2015-10-05 | Lysando Ag | METHOD FOR REDUCING biofilms |
-
2008
- 2008-08-26 GB GBGB0815484.1A patent/GB0815484D0/en not_active Ceased
-
2009
- 2009-08-25 MX MX2011001957A patent/MX2011001957A/es active IP Right Grant
- 2009-08-25 JP JP2011524360A patent/JP5153943B2/ja active Active
- 2009-08-25 BR BRPI0917508-3A patent/BRPI0917508A2/pt not_active Application Discontinuation
- 2009-08-25 EA EA201100312A patent/EA024794B1/ru not_active IP Right Cessation
- 2009-08-25 EP EP09782176A patent/EP2331687B1/en active Active
- 2009-08-25 US US13/061,053 patent/US9809808B2/en not_active Expired - Fee Related
- 2009-08-25 KR KR1020117006983A patent/KR101473271B1/ko active Active
- 2009-08-25 CA CA2735077A patent/CA2735077C/en active Active
- 2009-08-25 PL PL09782176T patent/PL2331687T3/pl unknown
- 2009-08-25 AU AU2009286760A patent/AU2009286760B2/en active Active
- 2009-08-25 DK DK09782176.3T patent/DK2331687T3/da active
- 2009-08-25 WO PCT/EP2009/060947 patent/WO2010023207A2/en not_active Ceased
- 2009-08-25 ES ES09782176T patent/ES2395357T3/es active Active
- 2009-08-25 CN CN200980142373.XA patent/CN102197132B/zh active Active
-
2011
- 2011-02-27 IL IL211441A patent/IL211441A/en active IP Right Grant
-
2012
- 2012-12-04 JP JP2012265070A patent/JP5571757B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2735077A1 (en) | 2010-03-04 |
| HK1157818A1 (en) | 2012-07-06 |
| EA024794B1 (ru) | 2016-10-31 |
| ES2395357T3 (es) | 2013-02-12 |
| US20110243915A1 (en) | 2011-10-06 |
| AU2009286760B2 (en) | 2015-08-27 |
| CN102197132B (zh) | 2016-01-13 |
| CN102197132A (zh) | 2011-09-21 |
| JP2013081465A (ja) | 2013-05-09 |
| MX2011001957A (es) | 2011-06-20 |
| JP2012500642A (ja) | 2012-01-12 |
| BRPI0917508A2 (pt) | 2015-08-04 |
| JP5153943B2 (ja) | 2013-02-27 |
| DK2331687T3 (da) | 2013-01-07 |
| EP2331687A2 (en) | 2011-06-15 |
| KR20110049883A (ko) | 2011-05-12 |
| GB0815484D0 (en) | 2008-10-01 |
| JP5571757B2 (ja) | 2014-08-13 |
| US9809808B2 (en) | 2017-11-07 |
| WO2010023207A3 (en) | 2010-07-15 |
| AU2009286760A1 (en) | 2010-03-04 |
| WO2010023207A2 (en) | 2010-03-04 |
| EP2331687B1 (en) | 2012-09-19 |
| EA201100312A1 (ru) | 2011-10-31 |
| IL211441A (en) | 2015-04-30 |
| KR101473271B1 (ko) | 2014-12-16 |
| CA2735077C (en) | 2019-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FIC20250007I1 (fi) | Fidanakogeenielaparvoveekki | |
| PL2331687T3 (pl) | Środki przeciwdrobnoustrojowe | |
| DK2370462T3 (da) | Glucagon-analoger | |
| DK2342317T3 (da) | Hængende-dråbe-plade | |
| DE602009000234D1 (de) | msignals | |
| BRPI0907376A2 (pt) | Fotobiorretador | |
| EP2258938A4 (en) | TYPE VEHICLE TO BE PROVIDED | |
| DK3444343T3 (da) | Polypeptider | |
| BRPI0914649A2 (pt) | Piprazolo-quinazolinas | |
| DE602008003972D1 (de) | Sitzrücklehnungsmechanismus | |
| EP2320913A4 (en) | NUCLEIC ACID APTAMERS | |
| DE602008003521D1 (de) | Sitzrücklehnungsmechanismus | |
| DK2342454T3 (da) | Vindkraftanlæg | |
| DK2336132T3 (da) | Morpholinpurinderivat | |
| DK2335031T3 (da) | In-line-måler | |
| EP2308156A4 (en) | STEP ACTUATOR | |
| DK2379557T3 (da) | Aminopyrazol-forbindelse | |
| DK2271613T3 (da) | Hydroxymethylcyklohexylaminer | |
| DE602008003970D1 (de) | Strahlstromkalibriersystem | |
| EP2257170A4 (en) | TETRAHYDROFUROPYRIDONE | |
| EP2318641A4 (en) | TOOL FOR CENTERING FOR DRILLING ENCLOSURE | |
| BRPI0907522A2 (pt) | biarlamidas | |
| DE112009000183A5 (de) | Sicherheitsvorreiber | |
| BRPI0909634A2 (pt) | 2-aminoquinolinas | |
| DE602009000862D1 (de) | Gehwagenbremse |